Hyperthermic intraperitoneal chemotherapy (HIPEC) after primary debulking surgery in advanced epithelial ovarian cancer: Is BRCA mutational status making the difference?
V. Ghirardi, Felice F. De, M. D'Indinosante, F. Bernardini, M. T. Giudice, Anna Fagotti, G. Scambia*
Risultato della ricerca: Contributo in rivista › Articolo
Fingerprint
Entra nei temi di ricerca di 'Hyperthermic intraperitoneal chemotherapy (HIPEC) after primary debulking surgery in advanced epithelial ovarian cancer: Is BRCA mutational status making the difference?'. Insieme formano una fingerprint unica.